MedTrace Logo

The Safety and Efficacy of an Enzyme Combination in Managing Knee Osteoarthritis Pain in Adults

NCT02088411 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2014-03-17

No results posted yet for this study

Summary

The aim of this randomized, double-blind, placebo-controlled, comparator-controlled trial was to evaluate the safety and efficacy of an enzyme combination, as Wobenzym®, in adults with moderate-to-severe osteoarthritis (OA) of the knee.

Conditions

Interventions

DRUG

Diclofenac

DIETARY_SUPPLEMENT

Wobenzym

OTHER

Placebo

Sponsors & Collaborators

  • Mucos Pharma GmbH, Oberhaching, Germany

    collaborator UNKNOWN

  • Atrium Innovations

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-11-30
Primary Completion
2001-11-30
Completion
2001-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02088411 on ClinicalTrials.gov